1887
Volume 2012, Issue 1
  • ISSN: 0253-8253
  • E-ISSN: 2227-0426

Abstract

Ischemic Optic Neuropathy (ION) is a rare complication of interferon (IFN) during treatment of Hepatitis C virus (HCV) with all reported cases occurring within three months of the start of therapy. We report a case of a late bilateral sequential ischemic optic neuropathy after 36 weeks of pegylated-interferon therapy. In contrast to previous reports, we recommend a regular ophthalmological follow-up throughout the whole course of interferon therapy.

Loading

Article metrics loading...

/content/journals/10.5339/qmj.2012.1.20
2012-06-01
2019-11-12
Loading full text...

Full text loading...

References

  1. Abe T, Nakojimo A, Satoh N, et al., Retinopathy associated with hepatitis C virus. Rinsho Ganka Jpn J Clin Ophthalmol. 1993; 47::227230.
    [Google Scholar]
  2. Schulman Joel A, Liang Chanping, Kooragayala Lakshmana M, King John. Posterior segment complications in patients with hepatitis C treated with interferon and ribavirin. Ophthalmology. 2003; 110:2:437442.
    [Google Scholar]
  3. Hosein Sean. Sight changes reported with PEG-interferon. HIV Treatment Bulletin. 2004; 5:, , CATIE News.
    [Google Scholar]
  4. Tu KL, Bowyer J, Schofield K, et al., Severe interferon associated retinopathy. Br J Ophthalmol. 2003; 87::247248.
    [Google Scholar]
  5. Cuthbertson FM, Davies M, McKibbin M. Is screening for interferon retinopathy in hepatitis Cjustified? Br J Ophthalmol. 2004 December; 88:12:15181520.
    [Google Scholar]
  6. Vardizer Yoav, Linhart Yifat, Loewen stein Anat, Garzozi Hanna, Mazawi Nail, Kesler Anat. Interferon-falphaj-Associated Bilateral Simultaneous Ischemic Optic Neuropathy. Journal of Neurophthalmology. December 2003; 23:4:256259.
    [Google Scholar]
  7. Yamada H, Mizobuchi K, Isogai Y. Acute onset of ocular complications with interferon. Lancet. 1994; 343::914.
    [Google Scholar]
  8. Hayasaka S, Fujii M, Yamamoto Y, Noda S, Kurome H, Sasaki M. Retinopathy and subconjunctival haemorrhage in patients with chronic viral hepatitis receiving interferon a Ifa. Br J Ophthalmol. 1995; 79::150152.
    [Google Scholar]
  9. Tadokoro Y, Ohtsuki H, Okano M, Furuse T. A case of disc edema during systemic interferon therapy. Folia Ophthalmol Jpn (Ganka- Kiyo). 1995; 46::653656.
    [Google Scholar]
  10. Fattovich G, Giustina G, Favarato S, Ruol A. A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon. J Hepatol. 1996; 24::3847.
    [Google Scholar]
  11. Hirokazu Ni, Yuichiro O, Kazuaki M, Waoko H, Murno H, Yoshihito H. Prednisolone, platelet- activating factor receptor antagonist, or superoxide dismutase reduced leukocyte antagonist, or superoxide dismutase reduced leukocyte entrapment induced by interferon alpha in retinal microcirculation. Invest Ophthalmol Vis Sci. 1997; 38::811816.
    [Google Scholar]
  12. Hayreh SS, Zimmerman B, Podhajsky P, Alward Wl. Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol. 1994; 117::603624.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/qmj.2012.1.20
Loading
  • Article Type: Case Report
Keyword(s): HCV , IFN therapy and sequential ION
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error